NICU Topic Reviews Flashcards
(395 cards)
What is the most common class of drug inducing a withdrawal state in the newborn?
Opioids
Is there duty to report a pending birth for intervention?
Birth alerts have been abolished in most of Canada - no duty to report for a fetus
Is OAT (opioid agonist therapy) recommended in pregnancy?
Yes - OAT during pregnancy reduces the risk of overdose and use of unregulated substances overlal, decreases infectious morbidity and improves prenatal care and obsetric/ neonatal outcomes
Buprenorphine preferred over methadone - less NAS
Preterm infants at higher or lower risk for NAS
Lower
Although symptoms may not be as apparent in prem infants
Signs/symptoms of neonatal abstinence syndrome?
- Wakefulness
- Irritability, tone, Moro reflex increased, inability to console, inability to coordinate oral feeding
- Tremors, temp instability or fever, tachypnea
- Hyperactivity, high pitched or excessive crying, hiccups, hypersensitivty to sounds, hyperreflexia (including yawning)
- Diaphoresis, disorganized suck, diarrhea (explosive), disturbed sleep, disruptive feeding behaviours (including excessive non-nutritive sucking and decreased oral intake)
- Respiratory distress, runny nose, regurgitation, rub marks (excoriation), rejecting feeds
- Apnea, autonomic dysfunction (heart and respiratory rate)
- Weight loss resulting in increased caloric demands
- Alkalosis (respiratory)
- Lethargy and lacrimation (eye-tearing)
- Snuffles, sneezing, seizures
Which agent has the most variable onseet to timing of symptoms of NAS?
Benzos - can be hours to weeks
All others 24 hours or 24-72 hours.
Methadone - 24 to 72 hours
Buprenorphine - 24 to 72 hours
Heroin - 24 hours
Fentanyl - 24 hours
Benzodiazepines - Hours to weeks depending on agent
When to check NAS score?
Within first 1-2 hours post-delivery, then every 3-4 hours thereafter (coordinate with sleep/wake cycles)
Evidence based alternative to Finnegan scoring?
Eat, Sleep, Console
ESC has been shown to decrease hospital length of stay (from 15 to 8 days) and need for pharmacological treatment, without increasing adverse events or readmissions significantly
Minimum duration that NAS scores should be conducted?
72 hours
Continue up to 120 hours with exposure to longer acting opioid
Continue throughout the initiation, duration, and discontinuation of pharmacological treatment, if prescribed
Examples of non-pharamacological interventions to implement at delivery for babies with risk for NAS:
Examples include skin-to-skin care, newborn-led care, safe swaddling, gentle waking, quiet environment, minimal stimulation, lower lighting, and developmental positioning
What intervention can delay the onset and decrease the severity of withdrawal symptoms and reduce the need for pharmacological treatment in NAS?
Human milk feeding (breastfeeding or expressed milk)
Which medication class has been associated with reduced treatment failure in NAS?
A 2021 Cochrane review - use of an opioid was associated with reduced treatment failure compared with phenobarbital, diazepam, or chlorpromazine
Name two acceptable / common first line medication options that are similarly safe and effective in NAS?
Morphine
Methadone
A few studies have reported shorter hospital length of stay with methadone compared to morphine
Name two commonly prescribed adjunct agents to opioids with NAS symptoms are not adequately controlled using a single agent?
Phenobarbital
Clonidine
Not enough evidence to guide which is preferable
Preferred adjunctive agent for NAS from polysubstance exposure including sedatives and hyponotics (benzos)?
Phenobarbital
Where opioid exposure has occurred prenatally or at time of delivery, or for the treatment of NAS, should naloxone be administered to a newborn?
No
- Naloxone can exacerbate underlying withdrawal syndrome including development of seizures
Dose of morphine in NAS?
0.03 to 0.05 mg/kg/dose every 3 to 4 h, orally
Increase by 0.03 to 0.05 mg/kg/dose as needed [58]
Weans are variable and patient-specific: Decrease by 10% to 20% every 24 to 48 h as tolerated
When is a newborn with NAS eligible for discharge?
When pharmacotherapy is not required within 72 hours for short- to 120 hours for long-acting opioids
However some practitioners opt to discharge newborns receiving pharmacological treatment to the community to continue to wean
- shown to be associated with fewer return visits to hospital to manage NAS
- saves $$$
- without increased adverse events or readmissions
Which infants are at the highest risk for repeated pain and related distress associated with physiological instability?
Very preterm infants
List at least 5 adverse outcomes of repeated exposure to pain in infancy:
- altered pain processing, cognition, and behaviour including executive function and visual abilities
- altered hypothalamic-pituitary-adrenal axis development and cortisol dysregulation
- reduced brain growth and structure
- altered thalamic development
- decreased frontal and parietal brain width
- altered diffusion measures and functional connectivity in the temporal lobes
- abnormalities in motor behaviour
- reduced cerebellar size
Which pain scoring tools have been most used in clinical trials in infants?
Premature Infant Pain Profile (PIPP / PIPP-R)
Neonatal Infant Pain Scale (NIPS)
Which non-pharmacological intervention is likely the most effective in reducing or preventing pain in neonates?
Direct breastfeeding before a procedure
- More effective in preventing pain than placebo or no treatment, swaddling, maternal holding, or skin-to-skin contact, topical anaesthetics, cooling spray, non-nutritive sucking, heel warming, music therapy, and sucrose
Name 4 non-pharmacological interventions to reduce pain in infants other than breastfeeding:
Skin to skin care
Non-nutritive sucking
Facilitated “tucking” or “containment” - better when combined with other interventions
Sucrose - small volumes repeatedly likely more benefit than a larger volume
Benefit to applying topical local anesthetic to skin before a heel lance or frenotomy?
No benefit seen in 8 RCTs
Some benefit before an LP but should be used with caution due to potential for systemic absorption especially in prem infants